These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18385166)

  • 21. [Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension].
    Blanco I; Villaquirán C; Valera JL; Molina-Molina M; Xaubet A; Rodríguez-Roisin R; Barberà JA; Roca J
    Arch Bronconeumol; 2010 Mar; 46(3):122-8. PubMed ID: 20138698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension complicating sarcoidosis.
    Nunes H; Uzunhan Y; Freynet O; Humbert M; Brillet PY; Kambouchner M; Valeyre D
    Presse Med; 2012 Jun; 41(6 Pt 2):e303-16. PubMed ID: 22608948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcoidosis-associated pulmonary hypertension.
    Cordova FC; D'Alonzo G
    Curr Opin Pulm Med; 2013 Sep; 19(5):531-7. PubMed ID: 23912192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience.
    Pabst S; Hammerstingl C; Grau N; Kreuz J; Grohe C; Juergens UR; Nickenig G; Skowasch D
    Adv Exp Med Biol; 2013; 755():299-305. PubMed ID: 22826080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pulmonary artery hypertension in patients with sarcoidosis (author's transl)].
    Rizzato G; Bertoli L; Merlini R; Tansini G; Scoccia S; Mantero O; Conti F
    G Ital Cardiol; 1980; 10(3):309-15. PubMed ID: 7372047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Six-minute walk test in sarcoidosis patients with cardiac involvement].
    Kowalska A; Puścińska E; Goljan-Geremek A; Czerniawska J; Stokłosa A; Kram M; Tomkowski WZ; Górecka D
    Pneumonol Alergol Pol; 2012; 80(5):430-8. PubMed ID: 22926904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of overestimation or underestimation of the functional capacity using MRC score as compared to 6-minute walk test in patients with cardio-respiratory disorders.
    Callens E; Graba S; Essalhi M; Gillet-Juvin K; Chevalier-Bidaud B; Chenu R; Mahut B; Delclaux C
    COPD; 2014 Sep; 11(5):496-502. PubMed ID: 24832477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients.
    Scheidl SJ; Englisch C; Kovacs G; Reichenberger F; Schulz R; Breithecker A; Ghofrani HA; Seeger W; Olschewski H
    Eur Respir J; 2012 Jan; 39(1):119-24. PubMed ID: 21737552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
    Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
    Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity.
    Miller KL; Kocak Z; Kahn D; Zhou SM; Baydush A; Hollis D; Folz RJ; Tisch A; Clough R; Yu X; Light K; Marks LB
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1009-13. PubMed ID: 15990002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sarcoidosis. Clinical presentation and prognosis].
    González EL; Vigliano C; Cáneva J
    Medicina (B Aires); 2010; 70(6):499-502. PubMed ID: 21163735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise capacity, muscle strength and fatigue in sarcoidosis.
    Marcellis RG; Lenssen AF; Elfferich MD; De Vries J; Kassim S; Foerster K; Drent M
    Eur Respir J; 2011 Sep; 38(3):628-34. PubMed ID: 21436356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
    Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
    Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data.
    Dobarro D; Schreiber BE; Handler C; Beynon H; Denton CP; Coghlan JG
    Am J Cardiol; 2013 Jan; 111(2):278-85. PubMed ID: 23290599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics.
    Shorr AF; Helman DL; Davies DB; Nathan SD
    Eur Respir J; 2005 May; 25(5):783-8. PubMed ID: 15863633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
    Shlobin OA; Kouranos V; Barnett SD; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Lower EE; Engel PJ; Wort J; Price L; Wells AU; Nathan SD; Baughman RP
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32139456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing cardiopulmonary exercise testing in severe COPD patients with and without pulmonary hypertension.
    Thirapatarapong W; Armstrong HF; Bartels MN
    Heart Lung Circ; 2014 Sep; 23(9):833-40. PubMed ID: 24793962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.